Endometriosis and Fertility: A Practical Guide

Susanne Beyer; Predrag Drazic; Franz Bitto; Alexander Boosz; Iris Brandes; Olaf Buchweitz; Radek Chvatal; Davut Dayan; Daniela Hornung; Elisabeth Janschek; Joerg Keckstein; Sylvia Mechsner; Lilo Mettler; Anja Mutz; Stefan Rimbach; Behrus Salehin; Sebastian Schäfer; Rasmus Schmädecker; Annemarie Schweizer-Arau; Karl-Werner Schweppe; Beata Seeber; Réné Wenzl; Monika Wölfler; Sonja Wüllner; Martin Sillem

doi:10.1055/a-2663-4218

Geburtshilfe und Frauenheilkunde, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd
DOI: 10.1055/a-2663-4218

GebFra Science

Statement

Endometriose und Fertilität – eine praktische Handreichung

Ergebnisse der Arbeitsgruppentagung Weissensee 2025 der Stiftung Endometriose Forschung Artikel in mehreren Sprachen: English | deutsch

Authors

Susanne Beyer

¹Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, LMU Klinikum, München, Germany (Ringgold ID: RIN27192)
Predrag Drazic

²Frauenklinik, Ammerland-Klinik GmbH, Westerstede, Germany (Ringgold ID: RIN39941)
Franz Bitto

³MIC-Zentrum München, München, Germany
Alexander Boosz

⁴Frauenklinik, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany (Ringgold ID: RIN15050)
Iris Brandes

⁵Institut für Epidemiologie, Sozialmedizin und Gesundheitssystemforschung, Medizinische Hochschule Hannover, Hannover, Germany (Ringgold ID: RIN9177)
Olaf Buchweitz

⁶Frauenklinik an der Elbe, Hamburg, Germany (Ringgold ID: RIN232672)
Radek Chvatal

⁷Klinik für Geburtshilfe und Gynäkologie, Znojmo Hospital, Znojmo, Czech Republic (Ringgold ID: RIN48246)
Davut Dayan

⁸Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Germany (Ringgold ID: RIN27197)
Daniela Hornung

⁹Helios Krefeld, Krefeld, Germany (Ringgold ID: RIN27664)

¹⁰Vinzentius Landau, Landau in der Pfalz, Germany
Elisabeth Janschek

¹¹LKH Villach, Villach, Austria (Ringgold ID: RIN31456)
Joerg Keckstein

¹²Stiftung Endometriose-Forschung/SEF, Westerstede, Germany
Sylvia Mechsner

¹³Klinik für Gynäkologie, Endometriosezentrum Charité, Charité – Universitätsmedizin Berlin, Berlin, Germany (Ringgold ID: RIN14903)
Lilo Mettler

¹⁴Emeritus Professor, Frauenklinik Kiel, Universitäts-Klinikum Schleswig Holstein, Kiel, Germany (Ringgold ID: RIN9179)
Anja Mutz

¹⁵Reproduktionsmedizin und Endokrinologie, Kinderwunschzentrum am Potsdamer Platz, Berlin, Germany
Stefan Rimbach

¹⁶Abteilung für Gynäkologie und Geburtshilfe, Krankenhaus Agatharied, Hausham, Germany (Ringgold ID: RIN167537)
Behrus Salehin

¹⁷Praxis Dr. med. Behrus Salehin, Mönchengladbach, Germany
Sebastian Schäfer

¹⁸Frauenheilkunde, Ludgerus Kliniken Münster, Clemenshospital, Münster, Germany (Ringgold ID: RIN39875)
Rasmus Schmädecker

¹⁹GZO Spital Wetzikon, Wetzikon, Switzerland (Ringgold ID: RIN219591)
Annemarie Schweizer-Arau

²⁰Akademie für Sinosomatics, Dießen, Germany
Karl-Werner Schweppe

¹²Stiftung Endometriose-Forschung/SEF, Westerstede, Germany
Beata Seeber

²¹Universitätsklinik für Gynäkologische Endokrinologie und Reproduktionsmedizin, Medizinische Universität Innsbruck, Innsbruck, Austria (Ringgold ID: RIN27280)
Réné Wenzl

²²Abteilung für Allgemeine Gynäkologie und Gynäkologische Onkologie, Medizinische Universität Wien/AKH Wien, Universitätsklinik für Frauenheilkunde, Wien, Austria (Ringgold ID: RIN31196)
Monika Wölfler

²³Abteilung für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Austria (Ringgold ID: RIN31475)
Sonja Wüllner

²⁴Wunschkinder Münster, Münstermann Höfe, Münster, Germany
Martin Sillem

²⁵Praxisklinik am Rosengarten, Mannheim, Germany

²⁶Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedizin, Universitätsklinikum des Saarlandes, Homburg, Germany (Ringgold ID: RIN39072)

Abstract

Zusammenfassung

Zielgruppe

An Endometriose und Sterilität interessierte Ärzte sowie das Behandlungsteam in Reproduktions- und Endometriosezentren.

Ziel

Handreichung für klinische Entscheidungen. Die vorliegende Arbeit ist das Ergebnis einer Arbeitsgruppe, die sich bei der Weissensee-Tagung 2025 der Stiftung Endometriose Forschung zusammengefunden hat. Grundlage war die verfügbare Evidenz zum Thema Fertilität, und, wo sie gefehlt hat, die klinische Erfahrung der Autorinnen und Autoren. Der Text ist gedacht als Handreichung für alle, die im klinischen Alltag Verantwortung für Patientinnen mit dieser Erkrankung tragen. Explizit nicht gedacht ist der Text als Vorgabe im Sinne einer Leitlinie, zumal hierzu die Autorinnen und Autoren nicht berufen sind. Vielmehr verfolgt er das Ziel, die Qualität des Vorgehens zu sichern und dadurch unnötige oder möglicherweise schädliche Maßnahmen möglichst zu vermeiden und für die individuelle Patientin die optimale Therapie festzulegen.

Schlüsselwörter

Endometriose - Kinderwunsch - Fertilität - Infertilität

Volltext

Referenzen

References/Literatur
1 Horne AW, Missmer SA. Pathophysiology, diagnosis, and management of endometriosis. BMJ 2022; 379: e070750
2 Singh S, Soliman AM, Rahal Y. et al. Prevalence, Symptomatic Burden, and Diagnosis of Endometriosis in Canada: Cross-Sectional Survey of 30000 Women. J Obstet Gynaecol Can 2020; 42: 829-838
3 Vander Borght M, Wyns C. Fertility and infertility: Definition and epidemiology. Clin Biochem 2018; 62: 2-10
4 Bulletti C, Coccia ME, Battistoni S. et al. Endometriosis and infertility. J Assist Reprod Genet 2010; 27: 441-447
5 Ozkan S, Murk W, Arici A. Endometriosis and infertility: epidemiology and evidence-based treatments. Ann N Y Acad Sci 2008; 1127: 92-100
6 Leone Roberti Maggiore U, Chiappa V, Ceccaroni M. et al. Epidemiology of infertility in women with endometriosis. Best Pract Res Clin Obstet Gynaecol 2024; 92: 102454
7 Van Gestel H, Bafort C, Meuleman C. et al. The prevalence of endometriosis in unexplained infertility: a systematic review. Reprod Biomed Online 2024; 49: 103848
8 Kanellopoulos D, Karagianni D, Pergialiotis V. et al. The interplay between endometriosis and fertility in rats: a systematic review. J Med Life 2022; 15: 742-746
9 Prescott J, Farland LV, Tobias DK. et al. A prospective cohort study of endometriosis and subsequent risk of infertility. Hum Reprod 2016; 31: 1475-1482
10 Nezhat C, Khoyloo F, Tsuei A. et al. The Prevalence of Endometriosis in Patients with Unexplained Infertility. J Clin Med 2024; 13: 444
11 Mori LP, Zaia V, Montagna E. et al. Endometriosis in infertile women: an observational and comparative study of quality of life, anxiety, and depression. BMC Womens Health 2024; 24: 251
12 Girard E, Mazloum A, Navarria-Forney I. et al. Women’s lived experience of endometriosis-related fertility issues. PLoS One 2023; 18: e0293531
13 Selntigia A, Molinaro P, Tartaglia S. et al. Adenomyosis: An Update Concerning Diagnosis, Treatment, and Fertility. J Clin Med 2024; 13: 5224
14 Sugimoto K, Nagata C, Hayashi H. et al. Use of dienogest over 53 weeks for the treatment of endometriosis. J Obstet Gynaecol Res 2015; 41: 1921-1926
15 Angioni S, Pontis A, Malune ME. et al. Is dienogest the best medical treatment for ovarian endometriomas? Results of a multicentric case control study. Gynecol Endocrinol 2020; 36: 84-86
16 Chodankar RR, Munro MG, Critchley HOD. Historical Perspectives and Evolution of Menstrual Terminology. Front Reprod Health 2022; 4: 820029
17 Becker CM, Bokor A, Heikinheimo O. et al. ESHRE Endometriosis Guideline Group. ESHRE guideline: endometriosis. Hum Reprod Open 2022; 2022: hoac009
18 Harmsen MJ, Van den Bosch T, de Leeuw RA. et al. Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedure. Ultrasound Obstet Gynecol 2022; 60: 118-131
19 Bourdon M, Santulli P, Marcellin L. et al. Adenomyosis: An update regarding its diagnosis and clinical features. J Gynecol Obstet Hum Reprod 2021; 50: 102228
20 Krentel H, Keckstein J, Füger T. et al. Accuracy of ultrasound signs on two-dimensional transvaginal ultrasound in prediction of adenomyosis: prospective multicenter study. Ultrasound Obstet Gynecol 2023; 62: 739-746
21 Moscarini M, Milazzo GN, Assorgi C. et al. Ovarian stripping versus cystectomy: recurrence of endometriosis and pregnancy rate. Arch Gynecol Obstet 2014; 290: 163-167
22 Piccioni MG, Rosato E, Muzii L. et al. Sonographic and clinical features of adenomyosis in women in “early” (18–35) and “advanced” (> 35) reproductive ages. Minerva Obstet Gynecol 2021; 73: 354-361
23 Vannuccini S, Meleca C, Toscano F. et al. Adenomyosis diagnosis among adolescents and young women with dysmenorrhoea and heavy menstrual bleeding. Reprod Biomed Online 2024; 48: 103768
24 Harmsen MJ, Trommelen LM, de Leeuw RA. et al. Uterine junctional zone and adenomyosis: comparison of MRI, transvaginal ultrasound and histology. Ultrasound Obstet Gynecol 2023; 62: 42-60
25 Kadam N, Khalid S, Jayaprakasan K. How Reproducible Are the Ultrasound Features of Adenomyosis Defined by the Revised MUSA Consensus?. J Clin Med 2025; 14: 456
26 Chapron C, Vannuccini S, Santulli P. et al. Diagnosing adenomyosis: an integrated clinical and imaging approach. Hum Reprod Update 2020; 26: 392-411
27 Vercellini P, Bonfanti I, Berlanda N. Adenomyosis and infertility: is there a causal link?. Expert Rev Endocrinol Metab 2019; 14: 365-367
28 Wang XL, Xu ZW, Huang YY. et al. Different subtypes of ultrasound-diagnosed adenomyosis and in vitro fertilization outcomes: A systematic review and meta-analysis. Acta Obstet Gynecol Scand 2023; 102: 657-668
29 Park CW, Choi MH, Yang KM. et al. Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. Clin Exp Reprod Med 2016; 43: 169-173
30 Niu Z, Chen Q, Sun Y. et al. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecol Endocrinol 2013; 29: 1026-1030
31 Hou X, Xing J, Shan H. et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod Biomed Online 2020; 41: 845-853
32 Gruber TM, Mechsner S. Pathogenesis of Endometriosis: The Origin of Pain and Subfertility. Cells 2021; 10: 1381
33 Mechsner S. Endometriosis, an Ongoing Pain-Step-by-Step Treatment. J Clin Med 2022; 11: 467
34 AWMF. Leitlinie Diagnostik und Therapie der Endometriose. AWMF-Registernummer 015–045. Leitlinienklasse S2k. Version 1.0. 2020 Zugriff am 01. März 2025 unter: https://register.awmf.org/de/leitlinien/detail/015-045
35 Guerriero S, Condous G, van den Bosch T. et al. Systematic approach to sonographic evaluation of the pelvis in women with suspected endometriosis, including terms, definitions and measurements: a consensus opinion from the International Deep Endometriosis Analysis (IDEA) group. Ultrasound Obstet Gynecol 2016; 48: 318-332
36 Keckstein J, Saridogan E, Ulrich UA. et al. The #Enzian classification: A comprehensive non-invasive and surgical description system for endometriosis. Acta Obstet Gynecol Scand 2021; 100: 1165-1175
37 Coelho Neto MA, Ludwin A, Borrell A. et al. Counting ovarian antral follicles by ultrasound: a practical guide. Ultrasound Obstet Gynecol 2018; 51: 10-20
38 Balachandren N, Kastora SL, Yasmin E. et al. An age-related nomogram for antral follicle count: an observational study of 3821 women. Reprod Biomed Online 2024; 49: 104295
39 Salemi F, Jambarsang S, Kheirkhah A. et al. The best ovarian reserve marker to predict ovarian response following controlled ovarian hyperstimulation: a systematic review and meta-analysis. Syst Rev 2024; 13: 303
40 Hariton E, Shirazi TN, Douglas NC. et al. Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals. Am J Obstet Gynecol 2021; 225: 515.e1-515.e10
41 Bernardi LA, Weiss MS, Waldo A. et al. Duration, recency, and type of hormonal contraceptive use and antimüllerian hormone levels. Fertil Steril 2021; 116: 208-217
42 Adamson GD, Pasta DJ. Endometriosis fertility index: the new, validated endometriosis staging system. Fertil Steril 2010; 94: 1609-1615
43 Montanari E, Bokor A, Szabó G. et al. Accuracy of sonography for non-invasive detection of ovarian and deep endometriosis using #Enzian classification: prospective multicenter diagnostic accuracy study. Ultrasound Obstet Gynecol 2022; 59: 385-391
44 Harth S, Kaya HE, Zeppernick F. et al. Application of the #Enzian classification for endometriosis on MRI: prospective evaluation of inter- and intraobserver agreement. Front Med (Lausanne) 2023; 10: 1303593
45 Fendal Tunca A, Iliman DE, Akdogan Gemici A. et al. Predictive value of preoperative MRI using the #ENZIAN classification score in patients with deep infiltrating endometriosis. Arch Gynecol Obstet 2023; 307: 215-220
46 Cobo A, Coello A, de Los Santos MJ. et al. Number needed to freeze: cumulative live birth rate after fertility preservation in women with endometriosis. Reprod Biomed Online 2021; 42: 725-732
47 Garcia-Velasco JA, Domingo J, Cobo A. et al. Five years’ experience using oocyte vitrification to preserve fertility for medical and nonmedical indications. Fertil Steril 2013; 99: 1994-1999
48 Cobo A, Giles J, Paolelli S. et al. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study. Fertil Steril 2020; 113: 836-844
49 Habbema JD, Eijkemans MJ, Leridon H. et al. Realizing a desired family size: when should couples start?. Hum Reprod 2015; 30: 2215-2221
50 Sänger N, Menabrito M, Di Spiezo Sardo A. et al. Fertility preservation counselling for women with endometriosis: a European online survey. Arch Gynecol Obstet 2023; 307: 73-85
51 Balcerek M, Barnbrock A, Behringer K. et al. Perspektive Fertilität: Indikation und Durchführung fertilitätsprotektiver Maßnahmen bei onkologischen und nicht-onkologischen Erkrankungen. Fertiprotekt. 2020 Zugriff am 01. März 2025 unter: https://fertiprotekt.com/wp-content/uploads/2020-Indikation-und-Durchfu%CC%88hrung-fertilitatsprotektiver-Masnahmen.pdf
52 Henry L, Vervier J, Boucher A. et al. Oocyte Cryopreservation in Patients with Endometriosis: Current Knowledge and Number Needed to Treat. J Clin Med 2022; 11: 4559
53 Bafort C, Beebeejaun Y, Tomassetti C. et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev 2020; 10 (10) CD011031
54 Keyhan S, Hughes C, Price T. et al. An Update on Surgical versus Expectant Management of Ovarian Endometriomas in Infertile Women. Biomed Res Int 2015; 2015: 204792
55 Crestani A, Merlot B, Dennis T. et al. Impact of Laparoscopic Sclerotherapy for Ovarian Endometriomas on Ovarian Reserve. J Minim Invasive Gynecol 2023; 30: 32-38
56 Younis JS, Shapso N, Izhaki I. Is ovarian reserve reduction following endometriotic cystectomy predicted? The implication for fertility preservation counseling. Front Endocrinol (Lausanne) 2022; 13: 996531
57 Zhang NN, Sun TS, Yang Q. An effective “water injection”-assisted method for excision of ovarian endometrioma by laparoscopy. Fertil Steril 2019; 112: 608-609
58 Moreno-Sepulveda J, Romeral C, Niño G. et al. The Effect of Laparoscopic Endometrioma Surgery on Anti-Müllerian Hormone: A Systematic Review of the Literature and Meta-Analysis. JBRA Assist Reprod 2022; 26: 88-104
59 Deckers P, Ribeiro SC, Simões RDS. et al. Systematic review and meta-analysis of the effect of bipolar electrocoagulation during laparoscopic ovarian endometrioma stripping on ovarian reserve. Int J Gynaecol Obstet 2018; 140: 11-17
60 Zhang CH, Wu L, Li PQ. Clinical study of the impact on ovarian reserve by different hemostasis methods in laparoscopic cystectomy for ovarian endometrioma. Taiwan J Obstet Gynecol 2016; 55: 507-511
61 Asgari Z, Rouholamin S, Hosseini R. et al. Comparing ovarian reserve after laparoscopic excision of endometriotic cysts and hemostasis achieved either by bipolar coagulation or suturing: a randomized clinical trial. Arch Gynecol Obstet 2016; 293: 1015-1022
62 Muzii L, Achilli C, Lecce F. et al. Second surgery for recurrent endometriomas is more harmful to healthy ovarian tissue and ovarian reserve than first surgery. Fertil Steril 2015; 103: 738-743
63 Iwase A, Nakamura T, Nakahara T. et al. Assessment of ovarian reserve using anti-Müllerian hormone levels in benign gynecologic conditions and surgical interventions: a systematic narrative review. Reprod Biol Endocrinol 2014; 12: 125
64 Yang F, Liu B, Xu L. et al. Age at surgery and recurrence of ovarian endometrioma after conservative surgery: a meta-analysis including 3125 patients. Arch Gynecol Obstet 2020; 302: 23-30
65 Daniilidis A, Grigoriadis G, Kalaitzopoulos DR. et al. Surgical Management of Ovarian Endometrioma: Impact on Ovarian Reserve Parameters and Reproductive Outcomes. J Clin Med 2023; 12: 5324
66 Crestani A, Dabi Y, Bendifallah S. et al. ENDOGRADE: A four level classification to rate surgical complexity in endometriosis. J Gynecol Obstet Hum Reprod 2023; 52: 102632
67 Özcan P, Varlı B, Sarıdoğan E. et al. Mechanisms of Endometrioma-Mediated Ovarian Damage: Myths and Facts. J Clin Med 2025; 14: 2147
68 Alborzi S, Hamedi B, Omidvar A. et al. A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Arch Gynecol Obstet 2011; 284: 105-110
69 Sesti F, Capozzolo T, Pietropolli A. et al. Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo. Eur J Obstet Gynecol Reprod Biol 2009; 147: 72-77
70 Vercellini P, Bracco B, Mosconi P. et al. Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study. Fertil Steril 2016; 105: 734-743.e3
71 Sutton C. The surgical management of Endometriosis. Curr Obstet Gynaecol 1993; 3: 133-138
72 Streuli I, de Ziegler D, Gayet V. et al. In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod 2012; 27: 3294-3303
73 Alkatout İ, Meinhold-Heerlein I, Keckstein J. et al. Endometriosis: A concise practical guide to current diagnosis and treatment. J Turk Ger Gynecol Assoc 2018; 19: 173-175
74 Hao HJ, Wang ZH, Feng L. et al. Which patients with hydrosalpinx will benefit more from reproductive surgery to improve natural pregnancy outcomes?: A systematic review and meta-analysis. Medicine (Baltimore) 2023; 102: e32806
75 Korell M, Seehaus D, Strowitzki T. et al. Endoskopische Diagnostik und Therapie bei tubarer Sterilität. Gynäkologe 1997; 30: 500-506
76 Melo P, Georgiou EX, Johnson N. et al. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2020; (10) CD002125
77 Chu J, Harb HM, Gallos ID. et al. Salpingostomy in the treatment of hydrosalpinx: a systematic review and meta-analysis. Hum Reprod 2015; 30: 1882-1895
78 Roman H, Chanavaz-Lacheray I, Ballester M. et al. High postoperative fertility rate following surgical management of colorectal endometriosis. Hum Reprod 2018; 33: 1669-1676
79 Casals G, Carrera M, Domínguez JA. et al. Impact of Surgery for Deep Infiltrative Endometriosis before In Vitro Fertilization: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol 2021; 28: 1303-1312.e5
80 Hudelist G, Korell M, Burkhardt M. et al. Rates of severe complications in patients undergoing colorectal surgery for deep endometriosis-a retrospective multicenter observational study. Acta Obstet Gynecol Scand 2022; 101: 1057-1064
81 Maignien C, Santulli P, Marcellin L. et al. Infertility in women with bowel endometriosis: first-line assisted reproductive technology results in satisfactory cumulative live-birth rates. Fertil Steril 2021; 115: 692-701